AbbVie says that Elahere is the first and only folate receptor alpha (FRɑ)-directed antibody drug conjugate (ADC) medicine ...

AbbVie (ABBV) shares snapped eight consecutive sessions of losses as the stock closed up XYZ% at $XYZ. The North ...

Most pharmaceutical businesses are slow-moving by nature due to the lengthy amount of time it takes to develop a new medicine ...

Last year, pharmaceutical giant AbbVie(NYSE: ABBV) lost patent exclusivity for its biggest cash cow, immunology medicine ...

Drugmakers such as AbbVie (ABBV.N), opens new tab and J&J are hustling for a share in an already-crowded market for drugs ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

Top-line results show that 64.7% of patients achieved clear or almost clear skin measured using the Investigator's Global ...

Within 10 years of Crohn's disease diagnosis, up to 50% of people will require surgery, with ileocaecal or ileocolonic resection being the most common procedure.1 Surgery is not curative and disease ...

Rio Tinto, Bougainville Copper, and Autonomous Bougainville Government form a Roundtable to address legacy impacts of Panguna ...

In 2023, pharmaceutical R&D expenditures worldwide exceeded USD 301 billion, with more than 5,500 companies investing in new treatments. Such increased focus on precision medicine and early diagnosis ...

VNS Health Total (HMO D-SNP)­ has earned five stars from the New York State Department of Health (NYSDOH), and received the highest Quality Incentive rating of any dual-eligible Medicaid Advantage ...

RVPH READ THE FULL RVPH RESEARCH REPORT Operational and Financial Results On November 14th, 2024, Reviva Pharmaceutical ...